Haploidentical Stem Cell Transplant With Post Transplant Cyclophosphamide for Chronic Granulomatous Disease With Thiotepa, Busulfan, and Fludarabine as Conditioning

被引：1
|
作者：
Kapoor, Rohit [1 ]
Rastogi, Neha [1 ]
Yadav, Satya P. [1 ]
机构：
[1] Medanta Medicity Hosp, Canc Inst, Pediat Hematol Oncol & Bone Marrow Transplant Uni, Gurgaon, Haryana, India
来源：
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2021年 / 43卷 / 04期
关键词：
SURVIVAL;
D O I：
10.1097/MPH.0000000000002015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [11] SAFETY OF T-CELL REPLETE HAPLOIDENTICAL STEM CELL TRANSPLANTATION USING FLUDARABINE, MELPAHALAN AND THIOTEPA CONDITIONING AND HIGH-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE
    Ciurea, S. O.
    de Lima, M.
    Kebriaei, P.
    Rondon, G.
    Saliba, R.
    McMannis, J.
    Andersson, B. S.
    Khouri, I. F.
    Giralt, S.
    Champlin, R. E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S218 - S218
  • [12] Thiotepa, Fludarabine and Busulfan conditioning regimen before T-cell replete haploidentical transplantation with post-transplant cyclophosphamide for AML and MDS : a bicentric experience of 109 patients
    Pagliardini, Thomas
    Castagna, Luca
    Harbi, Samia
    Rey, Jerome
    Furst, Sabine
    Bramanti, Stefania
    Legrand, Faezeh
    Maisano, Valerio
    Faucher, Catherine
    Granata, Angela
    Weiller, Pierre-Jean
    Calmels, Boris
    Lemarie, Claude
    Chabannon, Christian
    Vey, Norbert
    Blaise, Didier
    Devillier, Raynier
    BONE MARROW TRANSPLANTATION, 2018, 53 : 53 - 54
  • [13] A Single Center Experience Using Alemtuzumab, Fludarabine, Melphalan and Thiotepa as Conditioning for Transplant in Chronic Granulomatous Disease
    Bhatt, Sima
    Schulz, Ginny
    Hente, Monica
    Murray, Lisa
    Shenoy, Shalini
    Bednarski, Jeffrey J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S227 - S227
  • [14] Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia
    Saraceni, Francesco
    Beohou, Eric
    Labopin, Myriam
    Arcese, William
    Bonifazi, Francesca
    Stepensky, Polina
    Aljurf, Mahmoud
    Bruno, Benedetto
    Pioltelli, Pietro
    Passweg, Jakob
    Socie, Gerard
    Santarone, Stella
    Yakoub-Agha, Ibrahim
    Lanza, Francesco
    Savani, Bipin N.
    Mohty, Mohamad
    Nagler, Arnon
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (10) : 1211 - 1219
  • [15] Comparable Outcomes of AML Patients Receiving Haplo-HCT with Thiotepa/Busulfan/Fludarabine Conditioning and Post-Transplant Cyclophosphamide Versus a Matched Unrelated Donor with Fludarabine/Busulfan Conditioning, Regardless of Disease Status
    Bazarbachi, Ali
    Labopin, Myriam
    Blaise, Didier
    Forcade, Edouard
    Socie, Gerard
    Berceanu, Ana
    Bulabois, Claude Eric
    Kroger, Nicolaus
    Rambaldi, Alessandro
    Ceballos, Patrice
    Mielke, Stephan
    Yakoub-Agha, Ibrahim
    Savani, Bipin
    Spyridonidis, Alexandros
    Nagler, Arnon
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 23 - 24
  • [16] HAPLOIDENTICAL STEM CELL TRANSPLANT IN CHRONIC GRANULOMATOUS DISEASE: ONE CASE REPORT
    Ramirez-Uribe, Nideshda
    Blancas-Galicia, Lizbeth
    Lugo-Reyes, Saul
    Perez-Garcia, Martin
    Lopez-Hernandez, Gerardo
    Espinosa-Padilla, Sara
    Vargas-Olaya, Alberto
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (03) : 325 - 326
  • [17] Clofarabine followed by haploidentical stem cell transplant using fludarabine, busulfan, and total-body irradiation with post-transplant cyclophosphamide in non-remission AML
    Rakszawski, Kevin
    Miki, Kosuke
    Claxton, David
    Wagner, Henry
    Shike, Hiroko
    Mineishi, Shin
    Naik, Seema
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 108 (03) : 348 - 350
  • [18] Clofarabine followed by haploidentical stem cell transplant using fludarabine, busulfan, and total-body irradiation with post-transplant cyclophosphamide in non-remission AML
    Kevin Rakszawski
    Kosuke Miki
    David Claxton
    Henry Wagner
    Hiroko Shike
    Shin Mineishi
    Seema Naik
    International Journal of Hematology, 2018, 108 : 348 - 350
  • [19] Reduced Intensity Conditioning using Busulfan, Pentostatin, and Cyclophosphamide with post Transplant Cyclophosphamide in Patients with Hlh Undergoing Hematopoietic stem cell Transplant
    Morales, Sonia
    Kuntz, Nancy
    Benson, Monika
    Buchbinder, Barbara
    Lin, Carol
    Torno, Lilibeth
    Chavan, Rishikesh
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S17 - S18
  • [20] Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning
    Kerbauy, Fabio R.
    Rodrigues, Morgani
    de Souza Santos, Fabio Pires
    Sobrinho, Jairo Nascimento
    Kutner, Jose Mauro
    Torres, Margareth A.
    Feitosa Ribeiro, Andreza Alice
    de Lima, Marcos
    Hamerschlak, Nelson
    LEUKEMIA & LYMPHOMA, 2011, 52 (02) : 321 - 324
12345